<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Computerized_system_validation</id>
	<title>Computerized system validation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Computerized_system_validation"/>
	<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Computerized_system_validation&amp;action=history"/>
	<updated>2026-05-01T14:59:29Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.1</generator>
	<entry>
		<id>http://debianws.lexgopc.com/wiki143/index.php?title=Computerized_system_validation&amp;diff=2028674&amp;oldid=prev</id>
		<title>imported&gt;Toxophilus: Wikilink</title>
		<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Computerized_system_validation&amp;diff=2028674&amp;oldid=prev"/>
		<updated>2025-06-23T14:37:30Z</updated>

		<summary type="html">&lt;p&gt;Wikilink&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Previous revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:37, 23 June 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Short description|Process of quality control}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Short description|Process of quality control}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Computerized system validation&#039;&#039;&#039; (&#039;&#039;&#039;CSV&#039;&#039;&#039;) (Computerised system validation in European countries, and usually referred to as &quot;Computer Systems Validation&quot;) is the process of testing/validating/qualifying a regulated (e.g., US FDA 21 CFR Part 11&amp;lt;ref&amp;gt;{{Cite web|last=Commissioner|first=Office of the|date=2020-06-11|title=Part 11, Electronic Records; Electronic Signatures - Scope and Application|url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application|archive-url=https://web.archive.org/web/20190427214720/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application|url-status=dead|archive-date=April 27, 2019|access-date=2021-09-10|website=U.S. Food and Drug Administration|language=en}}&amp;lt;/ref&amp;gt;) computerized system to ensure that it does exactly what it is designed to do in a consistent and reproducible manner that is as safe, secure and reliable as paper-based records. This is widely used in the Pharmaceutical, Life Sciences and BioTech industries and is a cousin of Software Testing but with a more formal and documented approach.  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Computerized system validation&#039;&#039;&#039; (&#039;&#039;&#039;CSV&#039;&#039;&#039;) (Computerised system validation in European countries, and usually referred to as &quot;Computer Systems Validation&quot;) is the process of testing/validating/qualifying a regulated (e.g., US &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Food and Drug Administration|&lt;/ins&gt;FDA&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]] [[Title &lt;/ins&gt;21 CFR Part 11&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;|21 CFR Part 11]]&lt;/ins&gt;&amp;lt;ref&amp;gt;{{Cite web|last=Commissioner|first=Office of the|date=2020-06-11|title=Part 11, Electronic Records; Electronic Signatures - Scope and Application|url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application|archive-url=https://web.archive.org/web/20190427214720/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application|url-status=dead|archive-date=April 27, 2019|access-date=2021-09-10|website=U.S. Food and Drug Administration|language=en}}&amp;lt;/ref&amp;gt;) computerized system to ensure that it does exactly what it is designed to do in a consistent and reproducible manner that is as safe, secure and reliable as paper-based records. This is widely used in the Pharmaceutical, Life Sciences and BioTech industries and is a cousin of Software Testing but with a more formal and documented approach.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;The validation process begins with validation planning, system requirements definition, testing and verification activities, and validation reporting. The system lifecycle then enters the operational phase and continues until system retirement and retention of system data based on regulatory rules.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;The validation process begins with validation planning, system requirements definition, testing and verification activities, and validation reporting. The system lifecycle then enters the operational phase and continues until system retirement and retention of system data based on regulatory rules.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Similarly, The Rules Governing Medicinal Products in the European Union, Volume 4, Annex 11: Computerised Systems applies to all forms of computerized systems used as part of a GMP regulated activities and defines Computer System Validation Elements &amp;lt;ref&amp;gt;{{Cite web|last=EUROPEAN COMMISSION|date=2011-06-30|title=EudraLex, The Rules Governing Medicinal Products in the European Union Volume 4, Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, Annex 11: Computerised Systems|url=https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf|access-date=2023-03-11|website=European Commission|language=en}}&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Similarly, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&lt;/ins&gt;The Rules Governing Medicinal Products in the European Union&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&lt;/ins&gt;, Volume 4, Annex 11: &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&lt;/ins&gt;Computerised Systems&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039; &lt;/ins&gt;applies to all forms of computerized systems used as part of a GMP regulated activities and defines Computer System Validation Elements &amp;lt;ref&amp;gt;{{Cite web|last=EUROPEAN COMMISSION|date=2011-06-30|title=EudraLex, The Rules Governing Medicinal Products in the European Union Volume 4, Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, Annex 11: Computerised Systems|url=https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf|access-date=2023-03-11|website=European Commission|language=en}}&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==System requirement==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==System requirement==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>imported&gt;Toxophilus</name></author>
	</entry>
	<entry>
		<id>http://debianws.lexgopc.com/wiki143/index.php?title=Computerized_system_validation&amp;diff=440690&amp;oldid=prev</id>
		<title>imported&gt;GreenC bot: Rescued 2 archive links; reformat 1 link. Wayback Medic 2.5 per WP:URLREQ#fda.gov</title>
		<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Computerized_system_validation&amp;diff=440690&amp;oldid=prev"/>
		<updated>2025-05-29T20:25:40Z</updated>

		<summary type="html">&lt;p&gt;Rescued 2 archive links; reformat 1 link. &lt;a href=&quot;/wiki143/index.php?title=User:GreenC/WaybackMedic_2.5&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;User:GreenC/WaybackMedic 2.5 (page does not exist)&quot;&gt;Wayback Medic 2.5&lt;/a&gt; per &lt;a href=&quot;/wiki143/index.php?title=WP:URLREQ&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:URLREQ (page does not exist)&quot;&gt;WP:URLREQ#fda.gov&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Process of quality control}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Computerized system validation&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;CSV&amp;#039;&amp;#039;&amp;#039;) (Computerised system validation in European countries, and usually referred to as &amp;quot;Computer Systems Validation&amp;quot;) is the process of testing/validating/qualifying a regulated (e.g., US FDA 21 CFR Part 11&amp;lt;ref&amp;gt;{{Cite web|last=Commissioner|first=Office of the|date=2020-06-11|title=Part 11, Electronic Records; Electronic Signatures - Scope and Application|url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application|archive-url=https://web.archive.org/web/20190427214720/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application|url-status=dead|archive-date=April 27, 2019|access-date=2021-09-10|website=U.S. Food and Drug Administration|language=en}}&amp;lt;/ref&amp;gt;) computerized system to ensure that it does exactly what it is designed to do in a consistent and reproducible manner that is as safe, secure and reliable as paper-based records. This is widely used in the Pharmaceutical, Life Sciences and BioTech industries and is a cousin of Software Testing but with a more formal and documented approach. &lt;br /&gt;
The validation process begins with validation planning, system requirements definition, testing and verification activities, and validation reporting. The system lifecycle then enters the operational phase and continues until system retirement and retention of system data based on regulatory rules.&lt;br /&gt;
&lt;br /&gt;
Similarly, The Rules Governing Medicinal Products in the European Union, Volume 4, Annex 11: Computerised Systems applies to all forms of computerized systems used as part of a GMP regulated activities and defines Computer System Validation Elements &amp;lt;ref&amp;gt;{{Cite web|last=EUROPEAN COMMISSION|date=2011-06-30|title=EudraLex, The Rules Governing Medicinal Products in the European Union Volume 4, Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, Annex 11: Computerised Systems|url=https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf|access-date=2023-03-11|website=European Commission|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==System requirement==&lt;br /&gt;
Documented [[system requirements]] are required for CSV as they clearly stipulate the intended use of a computer system application. System requirements are gathered and documented in the system definition phase. System definition artifacts that reflect these requirements can include, but are not limited to, the following:&lt;br /&gt;
* [[User requirements specification|User Requirements Specification]]: Specifies required aims of the system. As opposed to specifying nice-to-have aims of the system.&lt;br /&gt;
* Hardware Requirements Specification: Minimum hardware required to support the system.&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[Software testing]]&lt;br /&gt;
* [[Software engineering]]&lt;br /&gt;
* [[List of software engineering topics]]&lt;br /&gt;
* [[Quality assurance]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
* [https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070336.pdf Guidance Compliance Regulatory Information]{{dead link|date=May 2025|bot=medic}}{{cbignore|bot=medic}}&lt;br /&gt;
&lt;br /&gt;
*[https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf EU GMP Annex 11: Computerised Systems]&lt;br /&gt;
&lt;br /&gt;
{{DEFAULTSORT:Computerized System Validation}}&lt;br /&gt;
[[Category:Quality control]]&lt;br /&gt;
[[Category:Software quality]]&lt;/div&gt;</summary>
		<author><name>imported&gt;GreenC bot</name></author>
	</entry>
</feed>